Demant A/S
CSE:DEMANT

Watchlist Manager
Demant A/S Logo
Demant A/S
CSE:DEMANT
Watchlist
Price: 200.6 DKK -1.47% Market Closed
Market Cap: kr42.5B

EV/S

2.6
Current
17%
Cheaper
vs 3-y average of 3.1

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
2.6
=
Enterprise Value
kr55.3B
/
Revenue
kr23B

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
2.6
=
Enterprise Value
kr55.3B
/
Revenue
kr23B

Valuation Scenarios

Demant A/S is trading below its 3-year average

If EV/S returns to its 3-Year Average (3.1), the stock would be worth kr242.29 (21% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-21%
Maximum Upside
+30%
Average Upside
13%
Scenario EV/S Value Implied Price Upside/Downside
Current Multiple 2.6 kr200.6
0%
3-Year Average 3.1 kr242.29
+21%
5-Year Average 3.4 kr260.94
+30%
Industry Average 3.2 kr245.4
+22%
Country Average 2.1 kr158.94
-21%

Forward EV/S
Today’s price vs future revenue

Today's Enterprise Value Revenue Forward EV/S
kr55.3B
/
Jan 2026
kr23B
=
2.6
Current
kr55.3B
/
Dec 2026
kr25.7B
=
2.1
Forward
kr55.3B
/
Dec 2027
kr27.4B
=
2
Forward
kr55.3B
/
Dec 2028
kr29.2B
=
1.9
Forward
kr55.3B
/
Dec 2029
kr31.1B
=
1.8
Forward
kr55.3B
/
Dec 2030
kr33.1B
=
1.7
Forward

Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
EV/S
P/E
All Countries
Close
Market Cap EV/S P/E
DK
Demant A/S
CSE:DEMANT
42.9B DKK 2.6 27.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
165.7B USD 15.9 58
US
Abbott Laboratories
NYSE:ABT
163B USD 3.6 26
US
Stryker Corp
NYSE:SYK
122.9B USD 5.3 37.9
IE
Medtronic PLC
NYSE:MDT
105.1B USD 3.5 22.8
US
Boston Scientific Corp
NYSE:BSX
86.7B USD 4.6 24.3
US
Edwards Lifesciences Corp
NYSE:EW
47.8B USD 7 43.6
DE
Siemens Healthineers AG
XETRA:SHL
39.8B EUR 2 18.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.3B USD 10.6 42.8
US
Becton Dickinson and Co
NYSE:BDX
42.6B USD 2.7 24.2
US
Resmed Inc
NYSE:RMD
31.6B USD 5.7 21.3

Market Distribution

In line with most companies in Denmark
Percentile
60th
Based on 439 companies
60th percentile
2.6
Low
0.1 — 0.8
Typical Range
0.8 — 3.5
High
3.5 —
Distribution Statistics
Denmark
Min 0.1
30th Percentile 0.8
Median 2.1
70th Percentile 3.5
Max 36.6

Demant A/S
Glance View

Demant A/S, an eminent player in the world of hearing healthcare, finds its roots in Denmark, where it was founded in 1904. The journey, sparked by the compassion of founder Hans Demant who sought ways to improve his wife's hearing experience, has evolved into a global operation focused on improving quality of life through innovative hearing solutions. Demant transcends beyond traditional hearing aids, carving a niche in providing a broad range of hearing healthcare services. These include audiometric equipment, hearing implants, diagnostic instruments, and personal communication applications, all aligned with the mission to help people overcome communication barriers. Key to Demant's strategy is its strong emphasis on research and development, ensuring that it remains at the forefront of technological advancements in audiology. The company monetizes its operations through a combination of cutting-edge product sales and a suite of ancillary services that cater to different segments of the hearing healthcare market. Leveraging a robust distribution network, Demant ensures a wide market reach, with offerings meticulously tailored to meet regional consumer needs. Collaborations with retailers, hospitals, and clinics across the globe amplify its market penetration, driving both revenue and brand loyalty. Additionally, Demant taps into the growing demand for auditory digital health solutions, offering cloud-based services that integrate seamlessly into consumer lifestyles. This multifaceted approach not only diversifies revenue streams but also fortifies Demant's standing as a holistic hearing solutions provider, underpinned by a commitment to enhancing living through auditory wellness.

DEMANT Intrinsic Value
265.61 DKK
Undervaluation 24%
Intrinsic Value
Price kr200.6
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett